Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip Bergquist

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Physiology & Behavior|February 25, 2014
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behaviorRozita H Anderberg, Christine Anefors, Filip Bergquist, et al.
Movement Disorders Clinical Practice|May 6, 2025
Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in SwedenFrida Hjalte, Anna Gustafsson, Jenny Samuelsson, et al.
Journal of Parkinson'S Disease|February 21, 2015
Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's DiseaseReinika Mitra, Patrik Aronsson, Michael Winder, et al.
Journal of Personalized Medicine|January 21, 2022
Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel InfusionGökçe Kilinçalp, Anne-Christine Sjöström, Barbro Eriksson, et al.
Rheumatology Advances in Practice|October 6, 2025
Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)Mats Dehlin, Filip Bergquist, Panagiota Drivelegka, et al.
Lakartidningen|March 11, 2020
[Parkinson's disease - heterogeneous and complex in its clinical presentation]Filip Bergquist, Anders Johansson, Nil Dizdar, et al.
Journal of Neurology|January 20, 2019
Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experienceIlias Thomas, Moudud Alam, Filip Bergquist, et al.
IEEE Journal of Biomedical and Health Informatics|July 11, 2018
A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor StatesIlias Thomas, Jerker Westin, Moudud Alam, et al.
Psychoneuroendocrinology|January 3, 2016
GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionalityRozita H Anderberg, Jennifer E Richard, Caroline Hansson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 12, 2012
The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptorsSuzanne L Dickson, Rozita H Shirazi, Caroline Hansson, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Physiology & Behavior|February 25, 2014
Dopamine signaling in the amygdala, increased by food ingestion and GLP-1, regulates feeding behaviorRozita H Anderberg, Christine Anefors, Filip Bergquist, et al.
Movement Disorders Clinical Practice|May 6, 2025
Health-Related Quality of Life in Relation to the 5-2-1 Criteria in Parkinson's Disease in SwedenFrida Hjalte, Anna Gustafsson, Jenny Samuelsson, et al.
Journal of Parkinson'S Disease|February 21, 2015
Local Change in Urinary Bladder Contractility Following CNS Dopamine Denervation in the 6-OHDA Rat Model of Parkinson's DiseaseReinika Mitra, Patrik Aronsson, Michael Winder, et al.
Journal of Personalized Medicine|January 21, 2022
Predictive Value of Ambulatory Objective Movement Measurement for Outcomes of Levodopa/Carbidopa Intestinal Gel InfusionGökçe Kilinçalp, Anne-Christine Sjöström, Barbro Eriksson, et al.
Rheumatology Advances in Practice|October 6, 2025
Association between gout, hyperuricaemia and Parkinson's disease risk: a cohort study in western Sweden (2001-2017)Mats Dehlin, Filip Bergquist, Panagiota Drivelegka, et al.
Lakartidningen|March 11, 2020
[Parkinson's disease - heterogeneous and complex in its clinical presentation]Filip Bergquist, Anders Johansson, Nil Dizdar, et al.
Journal of Neurology|January 20, 2019
Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson's disease: a first experienceIlias Thomas, Moudud Alam, Filip Bergquist, et al.
IEEE Journal of Biomedical and Health Informatics|July 11, 2018
A Treatment-Response Index From Wearable Sensors for Quantifying Parkinson's Disease Motor StatesIlias Thomas, Jerker Westin, Moudud Alam, et al.
Psychoneuroendocrinology|January 3, 2016
GLP-1 is both anxiogenic and antidepressant; divergent effects of acute and chronic GLP-1 on emotionalityRozita H Anderberg, Jennifer E Richard, Caroline Hansson, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 12, 2012
The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptorsSuzanne L Dickson, Rozita H Shirazi, Caroline Hansson, et al.
Pageof 7